Dr. Devette is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1200 Childrens Ave
# 14000
Oklahoma City, OK 73104Phone+1 405-271-6827
Summary
- Dr. Christa Devette is a pediatric specialist based in Oklahoma City, OK. She completed her medical education at the University of Oklahoma College of Medicine in 2020, followed by a residency in Pediatrics at the University of Oklahoma Health Sciences Center from 2020-2023. Prior to this, she studied at the University of Utah School of Medicine. Dr. Devette has several publications to her name, primarily focusing on pediatric conditions such as necrotizing enterocolitis. These articles have been published in reputable journals like Seminars in Perinatology, Clinical and Translational Medicine, Clinics in Perinatology, Theranostics, and Case Reports in Pediatrics and have been cited multiple times by other publications.
Education & Training
University of Oklahoma Health Sciences CenterResidency, Pediatrics, 2020 - 2023- University of Oklahoma College of MedicineClass of 2020
University of Utah School of MedicineClass of 2018
Certifications & Licensure
OK State Medical License 2021 - 2025- American Board of Pediatrics Pediatrics
Publications & Presentations
PubMed
- 43 citationsThe RON Receptor Tyrosine Kinase Promotes Metastasis by Triggering MBD4-Dependent DNA Methylation ReprogrammingStephanie Cunha, Yi Chun Lin, Elizabeth A. Goossen, Christa I. DeVette, Mark R. Albertella
Cell Reports. 2014-01-16 - 9 citationsAntigen presentation and interferon signatures in B cells driven by localized ablative cancer immunotherapy correlate with extended survival.Kaili Liu, Ashley R Hoover, Jason R Krawic, Christa I DeVette, Xiao-Hong Sun
Theranostics. 2022-01-01 - 11 citationsSingle-cell RNA sequencing reveals localized tumour ablation and intratumoural immunostimulant delivery potentiate T cell mediated tumour killing.Ashley R Hoover, Kaili Liu, Christa I DeVette, Jason R Krawic, Alexandra D Medcalf
Clinical and Translational Medicine. 2022-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
